[go: up one dir, main page]

AU8403098A - Reagents and methods for diagnosis and prognosis of proliferative disor ders - Google Patents

Reagents and methods for diagnosis and prognosis of proliferative disor ders

Info

Publication number
AU8403098A
AU8403098A AU84030/98A AU8403098A AU8403098A AU 8403098 A AU8403098 A AU 8403098A AU 84030/98 A AU84030/98 A AU 84030/98A AU 8403098 A AU8403098 A AU 8403098A AU 8403098 A AU8403098 A AU 8403098A
Authority
AU
Australia
Prior art keywords
prognosis
proliferative
reagents
diagnosis
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU84030/98A
Inventor
Giulio Draetta
Massimo Loda
Michele Pagano
Mark Rolfe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DEACONESS HOSPITAL
Agennix USA Inc
Original Assignee
DEACONESS HOSPITAL
MITOTIX Inc
Mitotix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DEACONESS HOSPITAL, MITOTIX Inc, Mitotix Inc filed Critical DEACONESS HOSPITAL
Publication of AU8403098A publication Critical patent/AU8403098A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G01N33/57595
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/118Prognosis of disease development
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701Details
    • G01N2333/4739Cyclin; Prad 1

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU84030/98A 1997-07-15 1998-07-14 Reagents and methods for diagnosis and prognosis of proliferative disor ders Abandoned AU8403098A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US89327697A 1997-07-15 1997-07-15
US08893276 1997-07-15
PCT/US1998/014566 WO1999004238A2 (en) 1997-07-15 1998-07-14 Reagents and methods for diagnosis and prognosis of proliferative disorders

Publications (1)

Publication Number Publication Date
AU8403098A true AU8403098A (en) 1999-02-10

Family

ID=25401315

Family Applications (1)

Application Number Title Priority Date Filing Date
AU84030/98A Abandoned AU8403098A (en) 1997-07-15 1998-07-14 Reagents and methods for diagnosis and prognosis of proliferative disor ders

Country Status (2)

Country Link
AU (1) AU8403098A (en)
WO (1) WO1999004238A2 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001525673A (en) * 1997-05-15 2001-12-11 トーマス ジェファーソン ユニバーシティ Determination of cyclin-dependent kinase inhibitor P27 level as a prognostic factor in cancer patients
US6972170B1 (en) 1997-12-01 2005-12-06 Sloan-Kettering Institute For Cancer Research Markers for prostate cancer
US7306926B2 (en) 1998-07-01 2007-12-11 Mtm Laboratories Ag Method for detecting carcinomas in a solubilized cervical body sample
EP1208232A4 (en) * 1999-06-10 2003-01-15 Sloan Kettering Inst Cancer PROSTATE CANCER MARKERS
DE19936618A1 (en) * 1999-08-04 2001-03-15 Monotec Gmbh Diagnostic kit and its use
AU1939601A (en) * 1999-12-01 2001-06-12 Ludwig Institute For Cancer Research Cancer associated antigens and uses therefor
US7906102B2 (en) 2001-10-03 2011-03-15 Vanderbilt University Ligands to radiation-induced molecules
US7306925B2 (en) 2001-11-09 2007-12-11 Vanderbilt University Phage antibodies to radiation-inducible neoantigens
EP1333278B1 (en) * 2002-02-01 2004-03-10 MTM molecular tools in medicine Methods for monitoring and prognosis of disease course of gastrointestinal tumors
IL149404A0 (en) * 2002-04-29 2002-11-10 Yissum Res Dev Co METHODS AND COMPOSITIONS FOR MODULATING β-CATENIN PHOSPHORYLATION
ATE261126T1 (en) * 2002-08-01 2004-03-15 Mtm Lab Ag PROCEDURE FOR SOLUTION-BASED DIAGNOSIS
ATE289685T1 (en) * 2003-08-25 2005-03-15 Mtm Lab Ag METHOD FOR DETECTING CARCINOMAS IN SOLUBILIZED CERVICAL BODY SAMPLES
MX359416B (en) 2010-07-27 2018-09-27 Genomic Health Inc Method for using gene expression to determine prognosis of prostate cancer.
WO2013019730A1 (en) 2011-07-29 2013-02-07 The Washington University Antibodies to tip-1 and grp78
EP3172222A4 (en) 2014-07-24 2018-03-21 Washington University Compositions targeting radiation-induced molecules and methods of use thereof
WO2018148595A1 (en) 2017-02-10 2018-08-16 Washington University Antibodies to tip1 and methods of use thereof

Also Published As

Publication number Publication date
WO1999004238A2 (en) 1999-01-28

Similar Documents

Publication Publication Date Title
AU8403098A (en) Reagents and methods for diagnosis and prognosis of proliferative disor ders
AU8766098A (en) Assay methods and apparatus
AU5155398A (en) Anti-ccr5 antibodies and methods of use therefor
AU4157696A (en) Quantitative method for early detection of mutant alleles and diagnostic kits for carrying out the method
AU2922497A (en) Detection probes, kits and assays
AU4235597A (en) Device and method for preventing assay interference
WO1999042118A8 (en) Compounds and methods for diagnosis of tuberculosis
AU7142796A (en) Diagnosis method and reagents
AU2299497A (en) An assay system and novel labelled compounds for use therewith
AU1810899A (en) Neuropilins and use thereof in methods for diagnosis and prognosis of cancer
AU2637299A (en) Method and kit for the detection of explosives
AU1650299A (en) Assay method and apparatus
GB9626932D0 (en) Assay methods and kits therefor
AU2735797A (en) Detection probes, kits and assays
AU3094895A (en) Method, reagents and kit for diagnosis and targeted screening for p53 mutations
AU2667197A (en) Stabilized preparations of human troponins and modifications thereof, diagnostic assay methods and assay kits
AU2787097A (en) Methods and apparatus for position determination
AU2871899A (en) Human receptor proteins; related reagents and methods
AU3005595A (en) Method, reagents and kit for diagnosis and targeted screening for retinoblastoma
AU4583397A (en) Assay for the detection of antibodies against p53
AU7571298A (en) Systems and methods for analyzing phantom images
AU4150999A (en) Method and kit for early diagnosis of cancer
AU1198899A (en) Reagents and immunoassay for the detection and quantitative determination of mycothiol and precursors thereof
AU5008996A (en) Method for the qualitative and quantitative detection of dna damage
AU1055997A (en) Luminescent probes for protein detection

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase